Harvard Bioscience, Inc. (HBIO)
USD 2.03
(-6.45%)
USD 2.03
(-6.45%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 9.49 Million USD | 989.18% |
| 2022 | 944 Thousand USD | -114.42% |
| 2021 | 11.31 Million USD | 41.27% |
| 2020 | 5.49 Million USD | -29.0% |
| 2019 | 7.5 Million USD | 245.69% |
| 2018 | 5.36 Million USD | 30.42% |
| 2017 | -101 Thousand USD | 13.47% |
| 2016 | 1.79 Million USD | 119.44% |
| 2015 | 1.72 Million USD | -92.3% |
| 2014 | 9.28 Million USD | 8.92% |
| 2013 | 7.66 Million USD | 3.05% |
| 2012 | 11.68 Million USD | -20.46% |
| 2011 | 11.94 Million USD | -28.83% |
| 2010 | 13.8 Million USD | 25.86% |
| 2009 | 13.13 Million USD | -32.64% |
| 2008 | 11.13 Million USD | 19.97% |
| 2007 | 9.53 Million USD | 6.74% |
| 2006 | 8.69 Million USD | -7.3% |
| 2005 | 12.96 Million USD | 23.86% |
| 2004 | 14.73 Million USD | -20.25% |
| 2003 | 12.95 Million USD | 47.66% |
| 2002 | 6.98 Million USD | -3.85% |
| 2001 | 3.75 Million USD | -67.42% |
| 2000 | -8.83 Million USD | -11.07% |
| 1999 | 2.39 Million USD | 1218.15% |
| 1998 | 2.43 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 424 Thousand USD | -255.67% |
| 2024 Q2 | -62 Thousand USD | 66.08% |
| 2023 Q3 | 473 Thousand USD | -73.91% |
| 2023 FY | - USD | 989.18% |
| 2023 Q1 | 3.13 Million USD | 167.43% |
| 2023 Q4 | 2.05 Million USD | 334.46% |
| 2023 Q2 | 1.81 Million USD | -42.21% |
| 2022 Q4 | 1.17 Million USD | 140.27% |
| 2022 FY | - USD | -114.42% |
| 2022 Q3 | -2.91 Million USD | -428.78% |
| 2022 Q2 | 886 Thousand USD | 118.77% |
| 2022 Q1 | 405 Thousand USD | -86.33% |
| 2021 Q4 | 2.96 Million USD | 57.81% |
| 2021 Q1 | 1.63 Million USD | -57.77% |
| 2021 Q3 | 1.87 Million USD | 13.35% |
| 2021 Q2 | 1.65 Million USD | 1.22% |
| 2021 FY | - USD | 41.27% |
| 2020 Q3 | 1.16 Million USD | -35.84% |
| 2020 Q4 | 3.87 Million USD | 231.96% |
| 2020 FY | - USD | -29.0% |
| 2020 Q1 | -1.73 Million USD | -124.04% |
| 2020 Q2 | 1.81 Million USD | 204.84% |
| 2019 FY | - USD | 245.69% |
| 2019 Q3 | 431 Thousand USD | -83.0% |
| 2019 Q4 | 7.21 Million USD | 1574.71% |
| 2019 Q2 | 2.53 Million USD | 107.79% |
| 2019 Q1 | 1.22 Million USD | -46.07% |
| 2018 FY | - USD | 30.42% |
| 2018 Q1 | -2.35 Million USD | -450.15% |
| 2018 Q3 | 2.47 Million USD | 98.32% |
| 2018 Q4 | 2.26 Million USD | -8.53% |
| 2018 Q2 | 1.24 Million USD | 153.0% |
| 2017 Q1 | 176 Thousand USD | -73.17% |
| 2017 FY | - USD | 13.47% |
| 2017 Q4 | 672 Thousand USD | -19.52% |
| 2017 Q3 | 835 Thousand USD | -13.11% |
| 2017 Q2 | 961 Thousand USD | 446.02% |
| 2016 Q3 | 883 Thousand USD | 254.62% |
| 2016 Q4 | 656 Thousand USD | -25.71% |
| 2016 Q1 | 809 Thousand USD | -1.82% |
| 2016 FY | - USD | 119.44% |
| 2016 Q2 | 249 Thousand USD | -69.22% |
| 2015 Q1 | -545 Thousand USD | -126.13% |
| 2015 Q3 | 468 Thousand USD | -55.89% |
| 2015 Q4 | 824 Thousand USD | 76.07% |
| 2015 FY | - USD | -92.3% |
| 2015 Q2 | 1.06 Million USD | 294.68% |
| 2014 Q1 | 2.44 Million USD | -63.06% |
| 2014 Q2 | 2.6 Million USD | 6.41% |
| 2014 FY | - USD | 8.92% |
| 2014 Q4 | 2.08 Million USD | -6.37% |
| 2014 Q3 | 2.22 Million USD | -14.5% |
| 2013 FY | - USD | 3.05% |
| 2013 Q4 | 6.63 Million USD | 662900.0% |
| 2013 Q3 | 1000.00 USD | -99.33% |
| 2013 Q2 | 150 Thousand USD | -83.15% |
| 2013 Q1 | 890 Thousand USD | -50.25% |
| 2012 Q3 | 642 Thousand USD | -68.06% |
| 2012 Q4 | 1.78 Million USD | 178.66% |
| 2012 Q1 | 2.07 Million USD | -15.81% |
| 2012 FY | - USD | -20.46% |
| 2012 Q2 | 2.01 Million USD | -2.95% |
| 2011 Q3 | 1.42 Million USD | -59.74% |
| 2011 Q2 | 3.52 Million USD | 36.39% |
| 2011 Q1 | 2.58 Million USD | -37.05% |
| 2011 FY | - USD | -28.83% |
| 2011 Q4 | 2.46 Million USD | 73.24% |
| 2010 Q2 | 3.24 Million USD | -8.57% |
| 2010 Q4 | 4.1 Million USD | 45.16% |
| 2010 FY | - USD | 25.86% |
| 2010 Q3 | 2.83 Million USD | -12.79% |
| 2010 Q1 | 3.54 Million USD | -10.65% |
| 2009 Q2 | 1.95 Million USD | -35.14% |
| 2009 Q1 | 3.01 Million USD | -40.47% |
| 2009 FY | - USD | -32.64% |
| 2009 Q4 | 3.97 Million USD | 46.46% |
| 2009 Q3 | 2.71 Million USD | 38.86% |
| 2008 Q1 | 3.24 Million USD | -11.55% |
| 2008 Q4 | 5.05 Million USD | 81.29% |
| 2008 FY | - USD | 19.97% |
| 2008 Q3 | 2.79 Million USD | -36.83% |
| 2008 Q2 | 4.41 Million USD | 36.33% |
| 2007 Q2 | 3.37 Million USD | 10.54% |
| 2007 Q1 | 3.05 Million USD | -7.14% |
| 2007 Q3 | 2.82 Million USD | -16.31% |
| 2007 FY | - USD | 6.74% |
| 2007 Q4 | 3.66 Million USD | 29.57% |
| 2006 Q4 | 3.29 Million USD | 19.93% |
| 2006 Q2 | 3.08 Million USD | 3.11% |
| 2006 Q1 | 2.99 Million USD | -5.5% |
| 2006 FY | - USD | -7.3% |
| 2006 Q3 | 2.74 Million USD | -11.0% |
| 2005 Q1 | 2.12 Million USD | -36.41% |
| 2005 Q2 | -1.52 Million USD | -172.05% |
| 2005 Q3 | 3.57 Million USD | 333.49% |
| 2005 Q4 | 3.16 Million USD | -11.37% |
| 2005 FY | - USD | 23.86% |
| 2004 Q3 | 2.9 Million USD | 21.93% |
| 2004 Q4 | 3.33 Million USD | 14.75% |
| 2004 Q2 | 2.38 Million USD | 24.8% |
| 2004 Q1 | 1.91 Million USD | -43.24% |
| 2004 FY | - USD | -20.25% |
| 2003 FY | - USD | 47.66% |
| 2003 Q2 | 3.49 Million USD | 84.96% |
| 2003 Q3 | 1.69 Million USD | -39.66% |
| 2003 Q4 | 4.08 Million USD | 24.98% |
| 2003 Q1 | 1.22 Million USD | -15.36% |
| 2002 Q2 | 1.48 Million USD | 11.17% |
| 2002 Q3 | 1.68 Million USD | 10.64% |
| 2002 Q1 | 1.18 Million USD | 48.77% |
| 2002 FY | - USD | -3.85% |
| 2002 Q4 | 1.34 Million USD | 26.93% |
| 2001 Q2 | 759 Thousand USD | 403.23% |
| 2001 Q3 | 24 Thousand USD | -88.44% |
| 2001 FY | - USD | -67.42% |
| 2001 Q1 | 1.03 Million USD | 103.82% |
| 2001 Q4 | 1.14 Million USD | 70.33% |
| 2000 FY | - USD | -11.07% |
| 2000 Q1 | 7.35 Million USD | 0.0% |
| 2000 Q4 | -32.39 Million USD | -540.37% |
| 2000 Q3 | 7.35 Million USD | 0.0% |
| 2000 Q2 | 7.35 Million USD | 0.0% |
| 1999 FY | - USD | 1218.15% |
| 1998 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 120.803% |
| AngioDynamics, Inc. | -14.29 Million USD | 166.422% |
| AtriCure, Inc. | -8.1 Million USD | 217.067% |
| Avinger, Inc. | -16.34 Million USD | 158.075% |
| Azenta, Inc. | 55.15 Million USD | 82.787% |
| BioLife Solutions, Inc. | -45.23 Million USD | 120.985% |
| The Cooper Companies, Inc. | 882.8 Million USD | 98.925% |
| Daxor Corporation | 329.74 Thousand USD | -2778.935% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 171.928% |
| Femasys Inc. | -13.16 Million USD | 172.084% |
| GlucoTrack, Inc. | -7.09 Million USD | 233.874% |
| Hologic, Inc. | 1.29 Billion USD | 99.268% |
| ICU Medical, Inc. | 307.69 Million USD | 96.915% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 99.603% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 200.994% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 80.623% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 244.377% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 244.377% |
| Masimo Corporation | 236.7 Million USD | 95.989% |
| Microbot Medical Inc. | -10.63 Million USD | 189.27% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 39.806% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 95.898% |
| Nephros, Inc. | -1.37 Million USD | 788.397% |
| NovoCure Limited | -175.86 Million USD | 105.398% |
| NEXGEL, Inc. | -2.73 Million USD | 447.729% |
| NEXGEL, Inc. | -2.73 Million USD | 447.729% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 110.975% |
| OraSure Technologies, Inc. | 76.15 Million USD | 87.535% |
| Pro-Dex, Inc. | 8.33 Million USD | -13.921% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 122.407% |
| Predictive Oncology Inc. | -13.18 Million USD | 172.015% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 477.913% |
| QuidelOrtho Corporation | 545.6 Million USD | 98.26% |
| Repligen Corporation | 124.29 Million USD | 92.362% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 3383.673% |
| STAAR Surgical Company | 33.22 Million USD | 71.425% |
| Sharps Technology, Inc. | -8.98 Million USD | 205.708% |
| Utah Medical Products, Inc. | 24.8 Million USD | 61.729% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 95.908% |
| Jin Medical International Ltd. | 3.44 Million USD | -175.728% |